Reproductive Flashcards
Leuprolide
GnRH analog
Agonist properties when used in pulsatile fashion
Antagonist properties when used in continuous fashion (downregulates GnRH receptor in pituitary to decrease FSH/LH)
“Leuprolide can be used in lieu of GnRH”
Leuprolide uses
GnRH analog Infertility = pulsatile Prostate cancer = continuous, used with flutamide Uterine fibroids = continuous Precocious puberty = continuous
Leuprolide toxicity
Antiandrogen
Nausea
Vomiting
Estrogens
Ethinyl estradiol
DES (Diethylstilbestrol)
Mestranol
Bind estrogen receptors
Estrogens
Toxicity?
Contraindications?
Increased risk of endometrial cancer
Bleeding in postmenopausal women
Clear cell adenocarcinoma of vagina in females exposed to DES in utero
Increased risk of thrombi
Contraindications = ER + breast cancer, history of DVTs
Selective estrogen receptor modulators = SERMs
Clomiphene
Tamoxifen
Raloxifene
Clomiphene
Uses?
Side effects?
SERM
Antagonist at estrogen receptors in hypothalamus
Prevents normal feedback inhibition and increases release of LH and FSH from pituitary = stimulates ovulation
Use = tx of infertility due to anovulation (PCOS)
SE = hot flashes, ovarian enlargement, multiple simultaneous pregnancies, visual disturbances
Tamoxifen
SERM
Antagonist on breast tissue
Agonist at uterus (risk cancer) and bone
Associated with endometrial cancer and thromboembolic events
Use = treat/prevent recurrence of ER + breast cancer
Raloxifene
SERM Agonist on bone Antagonist at uterus Increased risk of thromboembolic events Decreased resorption of bone = used to treat OSTEOPOROSIS
Hormone replacement therapy
Used for relief or prevention of menopausal symptoms (hot flashes, vaginal atrophy) and osteoporosis (increase estrogen, decrease osteoclast activity)
What is the risk with unopposed estrogen replacement therapy?
Increased risk of endometrial cancer
As a result, progesterone is added
Possible increased cardiovascular risk as well
Anastrozole and Exemestane
Aromatase inhibitors
Used in postmenopausal women with breast cancer
Progestins
Bind progesterone receptors = decrease growth and increase vascularization of endometrium
Uses = oral contraceptives; tx of endometrial cancer and abnormal uterine bleeding
Mifepristone (RU-486)
Use?
Toxicity?
Competitive inhibitor of progestins at progesterone receptors
Use = termination of pregnancy; administered with misoprostol (PGE1)
Toxicity = heavy bleeding, GI effects (n/v, anorexia), abdominal pain
Oral contraception (synthetic progestins, estrogen)
Estrogen and progestins inhibit LH/FSH and thus prevent estrogen surge
No estrogen surge = no LH surge = no ovulation